Cargando…

Comment to Sands et al. — No clinical benefit in mortality associated with hydroxychloroquine treatment in patients with COVID-19

Detalles Bibliográficos
Autor principal:	Hoang, Van Thuan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Author(s). Published by Elsevier Ltd on behalf of International Society for Infectious Diseases. 2021
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7903151/ https://www.ncbi.nlm.nih.gov/pubmed/33639295 http://dx.doi.org/10.1016/j.ijid.2021.02.079

Ejemplares similares

Clinical efficacy and safety profile of hydroxychloroquine and azithromycin against COVID-19
por: Gautret, Philippe, et al.
Publicado: (2021)

Re: ‘Effect of hydroxychloroquine with or without azithromycin on the mortality of COVID-19 patients’ by Fiolet et al.
por: Lacout, Alexis, et al.
Publicado: (2021)

Re: ‘Effect of hydroxychloroquine with or without azithromycin on the mortality of COVID-19 patients’ by Fiolet et al.
por: Million, Matthieu, et al.
Publicado: (2021)

Possible synergistic effects of hydroxychloroquine and steroids in COVID-19, time for a nuanced approach. Comment on Arshad et al.
por: Wiseman, David M.
Publicado: (2020)

Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open label non-randomized clinical trial revisited
por: Gautret, Philippe, et al.
Publicado: (2021)

Effect of hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial, an update with an intention-to-treat analysis and clinical outcomes
por: Gautret, Philippe, et al.
Publicado: (2021)

Response to effect estimation of hydroxychloroquine for COVID-19: a secondary analysis of an open label non-randomized clinical trial.
por: Gautret, Philippe, et al.
Publicado: (2021)

Response to the use of hydroxychloroquine in combination with azithromycin for patients with COVID-19 is not supported by recent literature.
por: Gautret, Philippe, et al.
Publicado: (2021)

Re: Effect of hydroxychloroquine with or without azithromycin on the mortality of COVID-19 patients: a systematic review and meta-analysis' by Fiolet et al.
por: Vedrines, Nicolas, et al.
Publicado: (2021)

Reply to the comment by Osuka et al.
por: Endo, Akira, et al.
Publicado: (2020)

Effect of hydroxychloroquine and azithromycin on the viral clearance of SARS-CoV-2: response to Hervé Seligmann
por: Gautret, Philippe, et al.
Publicado: (2021)

“ISTH guidelines for antithrombotic treatment in COVID‐19”: Comment from Huisman et al.
por: Huisman, Menno V., et al.
Publicado: (2022)

Response to uncertain effect of hydroxychloroquine and azithromycin on SARS-CoV-2 viral load.
por: Gautret, Philippe, et al.
Publicado: (2021)

A comment on Mokabel et al. (2017)
por: Basu, Saurav
Publicado: (2018)

Evidence inconclusive - comment on article by Schoenfeld et al
por: Beale, David J.
Publicado: (2016)

Comment on Arshad et al.: Treatment with Hydroxychloroquine, Azithromycin, and Combination in Patients Hospitalized with COVID-19
por: Varisco, Tyler J., et al.
Publicado: (2020)

Comment on trends in onomastics-the case of PCOS by Kalra et al.
por: Idiculla, Jyothi
Publicado: (2014)

A comment on a study by Yazdanpanahi et al. (2018)
por: Dkhar, Sabira A.
Publicado: (2018)

Comment on ‘COVID‐19: a major cause of cachexia and sarcopenia’ by Morley et al.
por: Zhou, Ling, et al.
Publicado: (2020)

Benefits, Burden, and COVID-19: A Response to Dutheil et al. (2020)
por: Rubenstein, Eric, et al.
Publicado: (2020)

Timing and dosage may be the key in the realisation of hydroxychloroquine + azithromycin treatment benefit in Covid-19 elderly patients
por: Lacout, Alexis, et al.
Publicado: (2021)

Reply to comment on Cruts et al. (2008), "Exposure to diesel exhaust induces changes in EEG in human volunteers" by Valberg et al
por: Crüts, Björn, et al.
Publicado: (2008)

The rationale for the use of colchicine in COVID-19: comments on the letter by Cumhur Cure M et al.
por: Piantoni, Silvia, et al.
Publicado: (2020)

Reply to Letter to the Editor by Griffiths et al. commenting on Evans & Allen
por: Evans, Bruce J.W., et al.
Publicado: (2017)

Comment on: Incidence of blindness in a population of rheumatic patients treated with hydroxychloroquine
por: Pareek, Anil, et al.
Publicado: (2019)

No evidence of rapid antiviral clearance or clinical benefit with the combination of hydroxychloroquine and azithromycin in patients with severe COVID-19 infection
por: Molina, J.M., et al.
Publicado: (2020)

Does Adding of Hydroxychloroquine to the Standard Care Provide any Benefit in Reducing the Mortality among COVID-19 Patients?: a Systematic Review
por: Patel, Tejas K., et al.
Publicado: (2020)

Safety considerations for chloroquine and hydroxychloroquine in the treatment of COVID-19
por: Gevers, S., et al.
Publicado: (2020)

A sound approach: Hydroxychloroquine reduces mortality in severe COVID-19
por: Zervos, Marcus, et al.
Publicado: (2020)

Lithium and renal tumors: a critical comment to the report by Zaidan et al.
por: Licht, Rasmus W, et al.
Publicado: (2014)

Comment on “Elucidating the relationship between noise sensitivity and personality” by Shepherd et al.
por: Dzhambov, Angel M.
Publicado: (2015)

Brief Comment on the Article about Human Anaplasmosis by Arraga-Alvarado et al.
por: de Tamí, Irene Maury, et al.
Publicado: (2015)

Improving Workplace Ergonomics in Corporate Offices: A Comment on Madhwani et al.
por: Basu, Saurav
Publicado: (2017)

Antidiabetic medication and quality of life: A comment on Chaturvedi et al. (2018)
por: Basu, Saurav
Publicado: (2018)

Comments on “Supervised Exercise Intervention and Overall Activity in CKD” by Pike et al.
por: Andrade, Francini Porcher, et al.
Publicado: (2020)

Comment on Flagel et al.: Sign-tracking as a predictor of addiction vulnerability
por: Pohořalá, Veronika, et al.
Publicado: (2021)

Obesity paradox in sarcopenia and knee osteoarthritis: comment on the article by Andrews et al
por: Mezian, Kamal, et al.
Publicado: (2021)

Comment on the CUSUM surgical learning curve analysis in Dimitrovska et al. (2022)
por: Rakovich, George, et al.
Publicado: (2022)

Fibromyalgia criteria and anomalous results: comment on the article by Ghavidel‐Parsa et al
por: Wolfe, Frederick, et al.
Publicado: (2022)

Comment on: incidence of blindness in a population of rheumatic patients treated with hydroxychloroquine: reply
por: Singh, Dilpreet K, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_kdehoe2hcdgfeqlojfdfg2ca93